Condensed Consolidated Statements of Net Loss (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue		$ 455,827	$ 313,663	$ 1,141,986	$ 944,187
Cost of goods sold		108,151	110,165	351,669	350,800
Gross profit		347,676	203,498	790,317	593,387
General and administrative expense		3,287,918	2,061,458	8,063,265	7,410,208
Operations expense		857,130	648,935	2,657,314	1,791,543
Sales and marketing expense		333,377	172,869	908,867	447,298
Loss on goodwill impairment		0	2,813,792	7,231,093	2,813,792
Total operating loss		(4,130,749)	(5,493,556)	(18,070,222)	(11,869,454)
Other income		63,047	58,830	146,524	144,122
Other expense		(2,001)	(7,413)	(5,207)	(244,214)
Gain on derivative instruments		10,219	4,122	107,381	68,884
Net loss		(4,059,484)	(5,438,017)	(17,821,524)	(11,900,662)
Net loss attributable to common shareholders per common shares-basic and diluted		$ (4,059,484)	$ (5,438,017)	$ (17,821,524)	$ (11,900,662)
Loss per common share basic and diluted (in dollars per share)		$ (0.05)	$ (0.08)	$ (0.25)	$ (0.23)
Weighted average shared used in computation – basic and diluted (in shares)	[1]	78,383,878	65,406,312	71,084,454	51,272,960

[1] The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive: Six Months ended June 30, 2022 2021 Options 1,035,245 1,013,780 Restricted Stock Units 366,666 325,000 Warrants 36,398,526 31,747,118 Preferred stock: series B 79,246 79,246